A curated clinical synthesis of 12 critical news developments, regulatory shifts, and emerging scientific publications in cannabis medicine for June 14, 2026.
Dr. Benjamin Caplan curates the top 10 developments in cannabinoid therapeutics, state cannabis regulatory frameworks, and clinical research for June 2, 2026.
Clinical trials and real-world registries demonstrate that cannabinoid therapies may help modulate severe behavioral dysregulation, anxiety, and sleep disruption in pediatric autism spectrum disorder. Because children possess distinct neurodevelopmental sensitivities and hepatic metabolic profiles, cannabinoid treatment requires specialized physician supervision, precise whole-plant formulation selection, and gradual micro-titration. Board-certified family physician Dr. Benjamin Caplan provides a comprehensive breakdown of clinical mechanisms, peer-reviewed evidence, and strict safety guidelines for families and clinicians.
Driven by viral social media trends claiming that smoking dried mullein leaf can ‘detox tar’ and cleanse the respiratory tract, millions of consumers are experimenting with herbal smoking blends. In an expert feature published by Men’s Health, board-certified family physician Dr. Benjamin Caplan explains why inhaling combusted plant matter is a misleading shortcut that irritates delicate bronchial tissue rather than healing it. This clinical analysis explores the pharmacology of Verbascum thapsus, compares oral demulcent teas against pulmonary combustion risks, and outlines medically sound pathways to restore lung health.
When everyday social interactions begin to feel exhausting, many individuals conclude that their personality has permanently changed or that they are becoming anti-social. In his Psychology Today column ‘Beyond the White Coat,’ board-certified family physician Dr. Benjamin Caplan argues that this tension reflects an acute depletion of nervous system capacity rather than an altered personal identity. Understanding the neurobiology of allostatic load, HPA axis stress fatigue, and restorative solitude allows individuals to heal burnout without withdrawing into permanent isolation.
⚠️ Medical Independence & Non-Endorsement Notice Notice Regarding Commercial Supplement Reviews: Dr. Benjamin Caplan was invited to provide purely physiological commentary regarding the metabolic mechanisms of green tea extract (EGCG)....
https://truthsocial.com/@realDonaldTrump/posts/115283887618990920 Visit The Commonwealth Project
The medical cannabis sector is undergoing a profound paradigm shift away from superficial wellness marketing and toward rigorous, evidence-based healthcare integration. Patients and healthcare providers increasingly demand precise cannabinoid dosing, comprehensive laboratory testing, and individualized clinical oversight to address complex health challenges. Board-certified physician and healthtech founder Dr. Benjamin Caplan reflects on his interview with CannabisInterviews.com, outlining four foundational ways the modern cannabis industry is maturing into legitimate clinical medicine.
